申请人:The Boots Company Limited
公开号:US04302460A1
公开(公告)日:1981-11-24
Compositions which contain a quinolone compound of the general formula ##STR1## wherein n is 0, 1 or 2; R.sub.1 is lower alkyl optionally substituted by hydroxy or C.sub.1-4 alkoxycarbonyl; allyl; propynyl or phenyl- lower alkyl in which the phenyl ring is optionally substituted by 1 or 2 C.sub.1-4 alkoxy groups; R.sub.2 is C.sub.1-4 alkyl with the proviso that when n is 0, R.sub.2 is methyl; and R.sub.3, R.sub.4 and R.sub.5, which may be the same or different, are hydrogen, lower alkyl, lower alkoxy, lower alkanoyl, halo, trifluoromethyl or lower alkylthio show antihypertensive activity. Compounds of general formula ##STR2## in which n, R.sub.1 R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as described above are novel subject to the following provisos (a) when R.sub.3, R.sub.4 and R.sub.4 and R.sub.5 are hydrogen R.sub.2 is methyl and R.sub.1 is lower alkyl, R.sub.1 contains more than one carbon atom, and (b) when R.sub.3 and R.sub.4 are hydrogen, R.sub.5 is hydrogen or 7-methyl, and R.sub.1 is ethyl, R.sub.2 contains more than one carbon atom. The specification describes and claims methods of making the compounds and novel intermediates used in such methods.
这个段落描述了含有喹诺酮化合物的组合物,其一般公式为##STR1##其中n为0、1或2;R.sub.1为可选择地被羟基或C.sub.1-4烷氧羰基取代的低烷基;烯丙基;丙炔基或苯基-低烷基,其中苯环可选择地被1或2个C.sub.1-4烷氧基取代;R.sub.2为C.sub.1-4烷基,但当n为0时,R.sub.2为甲基;R.sub.3、R.sub.4和R.sub.5,可能相同也可能不同,为氢、低烷基、低烷氧基、低烷酰基、卤素、三氟甲基或低烷硫基,显示抗高血压活性。一般公式为##STR2##中的化合物,其中n、R.sub.1、R.sub.2、R.sub.3、R.sub.4和R.sub.5如上所述,根据以下条件是新颖的:(a)当R.sub.3、R.sub.4和R.sub.5为氢时,R.sub.2为甲基,R.sub.1为低烷基,R.sub.1含有多于一个碳原子;(b)当R.sub.3和R.sub.4为氢时,R.sub.5为氢或7-甲基,R.sub.1为乙基,R.sub.2含有多于一个碳原子。该说明书描述和声称了制备这些化合物和用于这些方法的新颖中间体的方法。